Historical Stock Price
ETFs Holding CBIO »    CBIO Split History »



Video: Compound Annual Growth Rate (CAGR) Definition
Date Open High Low Close Volume
06/08/2026 $18.00 $18.34 $17.11 $17.28 238.30K
06/09/2026 $17.38 $18.23 $17.25 $18.00 126.20K
06/10/2026 $18.09 $18.76 $17.21 $17.57 169.10K
06/11/2026 $17.62 $19.04 $17.05 $18.34 139.30K
06/12/2026 $18.41 $19.05 $17.83 $17.92 182.00K
GlycoMimetics, Inc. is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including acute myeloid leukemia (AML) and for inflammatory diseases. It is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. Its drug candidates include Uproleselan, GMI-1687, Galectin Antagonists and GMI-1359.
CBIO historical stock prices picture
Crescent Biopharma (CBIO) has the following price history information. Looking back at CBIO historical stock prices for the last five trading days, on June 08, 2026, CBIO opened at $18.00, traded as high as $18.34 and as low as $17.11, and closed at $17.28. Trading volume was a total of 238.30K shares. On June 09, 2026, CBIO opened at $17.38, traded as high as $18.23 and as low as $17.25, and closed at $18.00. Trading volume was a total of 126.20K shares. On June 10, 2026, CBIO opened at $18.09, traded as high as $18.76 and as low as $17.21, and closed at $17.57. Trading volume was a total of 169.10K shares. On June 11, 2026, CBIO opened at $17.62, traded as high as $19.04 and as low as $17.05, and closed at $18.34. Trading volume was a total of 139.30K shares. On June 12, 2026, CBIO opened at $18.41, traded as high as $19.05 and as low as $17.83, and closed at $17.92. Trading volume was a total of 182.00K shares.

CBIO Historical Stock Prices By Date:

CBIO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Crescent Biopharma shares, starting with a $10,000 purchase of CBIO, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 06/14/2016
End date: 06/12/2026
Start price/share: $10,785.00
End price/share: $17.92
Starting shares: 0.93
Ending shares: 3.24
Dividends reinvested/share: $167.00
Total return: -99.42%
Average Annual Total Return: -40.25%
Starting investment: $10,000.00
Ending investment: $57.99
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/14/2016
End date: 06/12/2026
Start price/share: $10,785.00
End price/share: $17.92
Dividends collected/share: $167.00
Total return: -98.29%
Average Annual Total Return: -33.41%
Starting investment: $10,000.00
Ending investment: $171.43
Years: 10.00
Date Close
06/08/2026$17.28
06/09/2026$18.00
06/10/2026$17.57
06/11/2026$18.34
06/12/2026$17.92
CBIO is categorized under the Healthcare sector; below are some other companies in the same sector:

CBLI Historical Stock Prices
CBM Historical Stock Prices
CBMG Historical Stock Prices
CBMX Historical Stock Prices
CBMXW Historical Stock Prices
CBPO Historical Stock Prices
CBRX Historical Stock Prices
CBST Historical Stock Prices
CBSTZ Historical Stock Prices
CBYL Historical Stock Prices

Also explore: CBIO shares outstanding history

Email EnvelopeFree CBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

CBIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2026, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.